SURAKSHA
Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping… Read more
SURAKSHA - Asset Resilience Ratio
SURAKSHA (SURAKSHA) has an Asset Resilience Ratio of 10.91% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how SURAKSHA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down SURAKSHA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 0% |
| Short-term Investments | ₹414.87 Million | 10.91% |
| Total Liquid Assets | ₹414.87 Million | 10.91% |
Asset Resilience Insights
- Moderate Liquidity: SURAKSHA has 10.91% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
SURAKSHA Industry Peers by Asset Resilience Ratio
Compare SURAKSHA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for SURAKSHA (2021–2025)
The table below shows the annual Asset Resilience Ratio data for SURAKSHA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 5.35% | ₹178.59 Million | ₹3.34 Billion | -10.99pp |
| 2024-03-31 | 16.35% | ₹490.76 Million | ₹3.00 Billion | -1.48pp |
| 2023-03-31 | 17.82% | ₹501.17 Million | ₹2.81 Billion | +2.62pp |
| 2022-03-31 | 15.20% | ₹419.50 Million | ₹2.76 Billion | +11.16pp |
| 2021-03-31 | 4.04% | ₹69.10 Million | ₹1.71 Billion | -- |